RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. Timeline Annotations of the IXC Chart Story Thus Far - IXC IPO'd in mid 2019 with Phase II data due Mid 2020, stock performs very well on IPO with tight T20 - The stock rose in anticipation for the Mid 2020 Phase II data read out in early 2020 - Before crashing alongside the Covid 19 Market Crash Hysteria in March 2020 AND all volume the last 18 months has led to a higher T20 ownership) meanwhile we have a mere 3 posts regarding an IXC job listing for a CMO that's description can be interpreted as hinting at a second indication. ASX - By Stock. . pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - General. . Latest Posts ForumsHalf Yearly Report and AccountsLooks like people are starting to wake up here and realise how bloody cheap IXC is. **Close price adjusted for splits and dividend and/or capital gain distributions. . Last updated 10. ASX - By Stock. Commodities. . , page-2. , page-2. 10 cents a week and we will be at $2 plus in no time. . ASX - Day TradingCreated with Sketch. . Created with Sketch. 91%) As of 03:35PM EST. Expand. Latest Posts. Contrast that to data from Wales in 2017 which suggests that. Consequently, this would result in faster market penetration and an accelerated timeline to peak sales. IXC has alot of catching up to do. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Join the HotCopper ASX share market forum today for free. It's essentially a cashed up shell company right now it. 20 to $7. Discover historical prices for IXC. I see it at perhaps $5 prior to readout. ASX - Day TradingInvex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical. Created with Sketch. Australia's largest stock trading and investment forum Australia's #1 stock forumCreated with Sketch. ASX - General. 1. Only took that large seller to sell, now liquidity has dried up and. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only. . ASX - Day TradingCreated with Sketch. Last research or update on this I listened to was by FiftyOneCapital. 147,415. IXC Price at posting:. IXC Price at posting: 45. Advertise on HotCopper. We are a team of expert financial advisers each specialising in different, yet complementary areas. Created with Sketch. . , page-3. I'm doing my bit lolRecent success of NEU and ALA just goes to show there is money floating around, all IXC needs is a. Share Would anyone know whether the 28c cash backing strips out all of the options listed in the notice? or is it included and they will fall away on strike dates?wonder if the GLP-1 agonist referred to in this media release. Very impressive. @FullMoonFever Another chart request if you are up for it please thanks in advance, page-5. Ceasing to be a substantial holder. You’d be surprised the volume that comes in when this happenes, but by that stage you’ll be 100% up whilst the opportunity cost traders will be trying to catch the move up. 76 (-1. Umbrella Society is a proud Living Wage Employer! Greater Victoria's official living wage has been adjusted to $25. . Webinvest Pty Ltd<Olsb Unit A/C>. . 50%. Issue of Tranche 1 Placement Shares and Appendix 2A. Invex Therapeutics Ltd. ASX - Day Trading. ASX - By Stock. 6% $DLM 50. IXC Valuation Report MST. ASX - Day TradingIf IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. Interexchange carriers (IXCs) own or share the various high-bandwidth, fiber-optic trunk lines that cross the country and provide high-speed switched digital services for voice, data, and video communication. Discover historical prices for IXC. 7KB AVG: 22/11/2023 1:08 PM : 2023 AVG AGM Addresses and Presentation 35 pages 3. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. Created with Sketch. Market . . Invex Therapeutics Limited (ASX:IXC) is a biopharmaceutical company focused on the repurposing of an already approved drug, Exenatide, for efficacious. , page-4. Grabbed my first ever parcel in IXC yesterdy at 80c. is there any news release, or SP increasing due to only the market showing interestCreated with Sketch. Created with Sketch. ASX - By Stock. 4. ASX - By Stock. Notice of Investor Call and Presentation, page-3. Some people like to gamble on stocks, others invest. Latest Posts. . 54pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on INVEX THERAPEUTICS LTD. Cannot wait. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. , page-3. Transparency is our policy. ASX - By Stock. , page-3. Re-purposed FDA drug for other illness with amazing effect as domenstrated in P2 results which ever drove sp to $2. . Created with Sketch. Invex Granted Type C Meeting with FDA, page-2. Investor PresentationI would be worried about holding IXC if they had no more cash. ASX - By Stock. You’d be surprised the volume that comes in when this happenes, but by that stage you’ll be 100% up whilst the opportunity cost traders will be trying to catch the move up. 147,415. ASX - Day TradingCreated with Sketch. More progress made towards the start of Phase III, we have now made it on to the clinicltrials. Just a matter of time really. 5¢ Sentiment: Buy Disclosure: Held Ive compared IXC to NEU before and believe we approx. Maybe more common that what people think, imagine once GPs start diagnosing it even better if a treatment is developed, Prevalence could increase 2 or times which ultimately increases. 9 more clinical sites to be rapidly activated in a country with a growing incidence of IIH cases. ASX - Short Term Trading. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Forums. 3¢. 3¢. Created with Sketch. ASX - By Stock. Created with Sketch. gov and there is lots of good information about the trial. 50%. 0. Toubani Resources is an exploration and development company with a focus on developing a gold platform in West Africa. $45M MC $30M Cash and a $1. Created with Sketch. ASX - General. 64440. . *Close price adjusted for splits. The Chart: An Opportunity at these Levels?Timeline Annotations of the IXC Chart Story Thus Far- IXC IPO'd in mid 2019 with Phase II data due Mid 2020,. , page-196. ASX - Short Term Trading. . 3¢. , page-5. Invex Therapeutics Lists on ASX, page-3. . Given that IXC's Chief Scientific Officer, Alex Sinclair, is the author of IIH treatment guidelines, the introduction of an effective medication to the market would likely lead to a rapid integration of Presendin into treatment protocols. Update - Notification regarding unquoted securities - IXC. If IXC is positioning itself as a takeover target and the trial endpoints allow for it, it would make sense to provide early readouts. , page-5. 15M !Invex to Present at Bell Potter Healthcare ConferenceNotice of Annual General Meeting/Proxy Form, page-3. 64440. I'm talking about the period of the announcement about trials None of them moved apart from retailers that hosed out over 3 mill in shares. . View listing photos, review sales history, and use our detailed real estate filters to find the perfect place. IXC current EV is close to $0 so again Im not sure what OSL valuation is but I dont think it stacks up as good as IXC and where IXC is at in its timeline. Notice of Investor Call and Presentation, page-2. ASX - General. Created with Sketch. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. Bumping up this thread as $3. com. ASX - Day TradingMEDSAFE and Ethics Approval for IIH EVOLVE Trial in NZCreated with Sketch. ASX - Day TradingCreated with Sketch. Hi All, Having scrolled through the IXC forum for 18-24 months now, I have seen quite literally 200+ posts of charts discussing the stock price, and only a handful of posts discussing the fundamental analysis of the business itself,Publication of Invex IIH Phase II Pressure Trial Results. 1950. , page-6. Posted without a title, my bad hahaI was going for something like Invex - How much is it worth, when Phase 2 results hit in March 2020?Got this from IXC by email today. ASX - By Stock. LATEST NEWS: Toubani Resources releases MRE update for Kobada gold project, Mali. Latest Posts ForumsiShares Global Energy ETF (IXC) Add to watchlist NYSEArca - Nasdaq Real Time Price. Created with Sketch. Top 20 remains holding 58% compared to 58. ASX - Day TradingTo name a few other biotechs that have gotten belted by the market of the last few months that have had decent bounces such as NOX, NYR and PEB. ASX - Day Trading. is there any news release, or SP increasing due to only the market showing interest, page-2. Loading interactive chart. ASX - Day Trading. Latest Posts. . Created with Sketch. Share No great change in the top 2 big boys who hold 17% of the company, Twiggy's fund unchanged. . ASX - Day TradingInitial FDA and EMA Advice on Presendin Development, page-2. Created with Sketch. Created with Sketch. IXC needs to be proactive and release a statement. You are the controller for IXC, you call the shots to make the company as best as possible for shareholders - this means retaining talent and forwarding the company to Phase III success and beyond. Created with Sketch. I think having this out we can discuss on the way. ASX - General. ASX - By Stock. Been. Australian finance news, stock quotes, currency information and blogs Active Funds. . ASX - Short Term Trading. Although, IXC is trading about 3-4x lower than what I expect it to be. 05. Australia's largest stock trading and investment forum Australia's #1 stock forum Australia's #1 stock forumFound this article a while back although raises some decent points. A new thread to put trading comments / reasoning / opinions in. Created with Sketch. ASX - By Stock. 5¢ INVEX THERAPEUTICS LTD - Discussion. 0¢ Sentiment: Buy Disclosure: Held Created with Sketch. ASX - General. Anyone had a look at this or put an application in for some stock in the IPO?Created with Sketch. Created with Sketch. Both approaches can work, but it is not wise to confuse the two. Notification of cessation of securities - IXC. Invex Therapeutics Lists on ASXNo worries mate :), page-15. Join the HotCopper ASX share market forum today for free. ASX - Day TradingSomeone bought $500 stock today at 44 cents. ASX - Short Term Trading. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. 79 -0. ASX - By Stock. Latest Posts. We are supported by a Board of Advice which is made up of the premier leaders in the various fields in which we, Private Capital Advisers, specialise. Market open. . ASX - Short Term Trading. Created with Sketch. 59pm 09/11/2023 ? HotCopper has news, discussion, prices and market data on INCITEC PIVOT LIMITED. Target our investor community with our suite of Hotcopper Advertising opportunities. 38 Biotechnology stocks are valued based on a risk. GW Ixc once again showing why you are the best mgmt team on the ASX . ASX - By Stock. Invex Therapeutics Ltd. IXC is at base, so it’s just a matter of when it’ll leave base and start turning to the upside. All IMO IXC Price at posting: 37. ASX - Day Trading. For IXC I see the risk in one indication, comparatively lower TAM than others and different formulation for a week duration while phase II used daily. Interexchange Carrier, also known as IXC, is a telco that mainly provides long-distance communication services. Good fundamental research starting points for IXC:Summary: IXC FactsheetMST Analyst Equity Research ReportFiftyOne Capital ReportPresentation - Tom Duthy. Charts. Created with Sketch. Created with Sketch. pdfGreat to see initiation of research from MST today, click the link to read the full report or read the first page in post. ASX - General. 20. *Close price adjusted for splits. 1073084. Ceasing to be a substantial holderAustralian finance news, stock quotes, currency information and blogsQuarterly Activities/Appendix 4C Cash Flow ReportInvex Granted European Patent for Exenatide in Hydrocephalus. , page-35. Report to HotCopper and itll be the end of it, cheers. , page-4. 69KBThis doesn't mean that IXC is doomed, just that things are more a gamble than an investment at the moment. ASX - Day TradingIf anyone told me a year ago, "there is a chance IXC cant progress the trial and the management all get sacked" I would agree that there was a chance, but nullified to a 1-2% black swan and worth the upside return profile. At the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. Target our investor community with our suite of Hotcopper Advertising. Initial FDA and EMA Advice on Presendin Development, page-3. , page-4. Forums. ASX - By Stock. HotCopper has news, discussion, prices and market data on IXUP LIMITED. The Calmer Co (ASX:CCO) breaks new ground in Australian Retail with Kava shots to launch in Coles from January 2024Hi guys, after discussion with Tom I have kind of mapped out the timeline to what is to be achieved. 5¢ Sentiment: Buy Disclosure: HeldAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. My. . , page-188. 1950. So your thesis is right on a long time time frame. Charts. 59 before first real pull back (those lines will be used in the future, they always set it up for that reason, being $3. Invex Files Pre-IND/Type B Meeting Request with US FDAIXC is a long term play mate, not a daytraders plaything as too illiquid. Spot on - filled the 1. Advertise on HotCopper. ASX - By Stock. 5¢ Sentiment: Hold Disclosure: Held IXC Valuation Report MST. ASX - By Stock. IXC below Example of that is NEUInvestor Presentation, page-3. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving. Below is the broker data for IXC November to. Market open. We are a team of expert financial advisers each specialising in different, yet complementary areas. 1950. . you post every single trade that is a sell onto Hotcopper. 10 Upvote. 0. ASX - Day TradingAnother day…another approval. Probably been disappointed like all of usCreated with Sketch. Invex Receives Approval for Paediatric Plan from the EMA, page-3. ASX - General. ASX - Short Term Trading. IXC Valuation Report MST. Charts. Created with Sketch. Australia's largest stock trading and investment forum Australia's #1 stock forumIXC peaked at $1. Market . Withdrawal of AGM Resolutions, page-2. Should jump back in Titans, was good having you on board as you know your stuff IXC Price at posting: 57. Created with Sketch. ASX - Day Trading It is certainly an interesting case study regarding management strategy; that noted strategy would work during fair or bullish markets as participants are acting rationally (and by sticking to their knitting during Covid Crash the IXC share price bounced back heavily with Phase II results - so perhaps thats what they were thinking would happen. Liked by Jackie Cox-Ziegler, CPHR. 1. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical developmentNotice of Annual General Meeting/Proxy Form. . A rolling snowball gathers snow as it falls down the hill . I bought the chart from base lows looking for a trade. AX stock on Yahoo Finance. , page-2. 3¢. 2 years ago biotech stocks were in vogue and hence NEU was fairly priced at $1. ASX - Day TradingHere's a very good opportunity for people in Sydney. Thought that this would be worthy of its own thread, a great starting place for those new to IXC and arguably the best presentation to date, Worth a. ASX - Day Trading. Charts. ASX - Short Term Trading. Charts. Not sure what software this is but is there a way you can send the document itself, is a tad tough to read it with the photo you sent, if not all good, page-4. Created with Sketch. . Information. . I knew zero about the fundamentals of IXC. Charts. here (arrow) per the NEU chart Close now to breaking trend and establishing a more upper trend into results IMO IXC Price at posting: 40. Sentiment for Invex Therapeutics Ltd. Created with Sketch. ASX - By Stock. Plans & Pricing. IXC Price at posting: 38. If nothing has occurred with IXC for 2-3 days, we are happy to see no posts for 2-3 days, when there is excitement around a new development, then we can all get together to discuss and speculate. Most bio's get acquired on P2 readouts, if results are strong early here. ASX - Day TradingAlthough with IXC fully cashed up it makes this fall irrational and the odd one out of alot of these small cap speccies that are death spiralling - aka, opportunity . Join the HotCopper ASX share market forum today for free. Invex Granted Type C Meeting with FDA, page-3. ASX - By Stock. Interested to hear that Scott believes the company didn't have the phase 2 data for the initial meeting with FDA/EMA. Anyone had a look at this or put an application in for some stock in the IPO?, page-2. Share IXC needs to be proactive and release a statement. . Created with Sketch. You are still able to buy a potential multi BILLION dollar company in the 50 mill MC range. Most bio's get. Created with Sketch. EGREcoGraf partners with VinES Energy for pioneering Battery Anode Material Facility in Vietnam. INVEX THERAPEUTICS LTD (ASX:IXC) - IXC chart, page-1 - HotCopper | ASX Share Prices, Stock Market & Share Trading Forum Forums ASX - By Stock IXC IXC chart IXC invex therapeutics ltd IXC chart 1 Last ralom 17,015 Posts. . Given the quality of the posters on the IXC thread I am confident others will do the same. . , page-3. 30 Haven’t supported share price since then on market . @FullMoonFever Another chart request if you are up for it please thanks in advance, page-3. . Investor PresentationInvex Successfully Concludes Protocol Assistance with EMACreated with Sketch. IXC (ASX) Ann: Trading Halt - HotCopper. 1 Upvote. Postcard to ShareholdersIXC (ASX) Ann: Trading Halt - HotCopper. 0% $ODM 35. This is fantastic news and I appreciate the fact that it has not been heavily hyped by the company, makes you wonder what else is being worked on. is 19. Forums. Latest Posts. Advertise on HotCopper. 0¢ Sentiment: Buy Disclosure: Held. Appendix 4C - quarterlyAt the request of a few posters who want to start afresh, welcome to the IXC charting thread going forward!If you're a poster who is inclined to track TA,. boolish Jellyroll hey. IXC on the other hand with nearer catalysts has already done its basing cycle Of course different stock different TAMS etc etc, probably why IMU is worth 640 mill MC and IXC 28 mill MC But again its why IXC is offering so much more in terms of value atm plus risk v reward All IMO of course, but yeh maybe some IMU investors pop across. Invex Receives Approval for Paediatric Plan from the EMA, page-2. Exciting times now that IXC is finally on the map!!! FYI considering charting is subjective that 1. Latest Posts. When can we expect some update or. Invex Granted Key European Patent for Exenatide, page-2. Join the HotCopper ASX share market forum today for free. Created with Sketch. But since the cash holding is double the market cap, there most likely more upside than down side. Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of. no point selling now. 30 to $15 in the space of 1 and half years Bios move fast when value is recognised. Created with Sketch. Withdrawal of AGM ResolutionsInvex Granted Key European Patent for Exenatidehe’s known for the vend etc like asxcowboy has pointed out. Created with Sketch. Learn more.